Research Paper Volume 15, Issue 11 pp 5125—5143
Network pharmacology-based research on the effect of angelicin on osteosarcoma and the underlying mechanism
Figure 9. CCK8 assay. Angelicin inhibited the proliferation of osteosarcoma MG63 cells. The viability of osteosarcoma MG63 cells was measured at different time points (24 h, 48 h, or 72 h) of culture with media containing different angelicin concentrations (3.125–400 μmol/ml), and the results are shown as the mean ± standard deviation.